Skip to main content
U.S. flag

An official website of the United States government

Sodium phenylacetate and sodium benzoate

Published by U.S. Food and Drug Administration | U.S. Department of Health & Human Services | Catalog Last Checked: February 18, 2026 at 08:12 AM | Dataset Last Updated: March 17, 2025
Sodium Phenylacetate and Sodium Benzoate is an intravenous injection solution containing 100 mg/mL of each active ingredient. Manufactured by MAIA Pharmaceuticals, Inc., it's a prescription drug used to help remove excess ammonia from the blood in patients with certain metabolic disorders. Administered via IV infusion, it works by binding nitrogen compounds for excretion. This information was generated using AI and is provided for informational and research purposes only.

Resources

1 resource available

  • Sodium phenylacetate and sodium benzoate

    TEXT/HTML

Find Related Datasets

Search by Tags

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov